Tjoapack Announces Major U.S. Expansion with New 170,000-sq-ft Pharmaceutical Packaging Facility

10 December 2025 | Wednesday | News

New GMP facility will add high-speed packaging lines, labeling, and extensive cold-chain capacity, with completion expected in early 2027.

Tjoapack, a leading global contract packaging organization, has announced a significant strategic investment to expand its operational footprint in the U.S., strengthening its position as a trusted partner in pharmaceutical supply chain solutions.

The company  is developing a new 170,000-square-foot facility adjacent to its existing site in Clinton, Tennessee. The expansion will feature a comprehensive GMP suite, including packaging , labeling, cold chain and ambient storage capabilities to accommodate the rising client demand. 

Scheduled for completion in early 2027, the new addition will support new high-speed packaging lines across a range of dosage forms, including oral solid dose (bottles and blisters) and injectable products (vials and auto-injectors), as well as various secondary packaging configurations. 

 This expansion reflects the company’s ongoing commitment to investing in infrastructure that enhances service flexibility and addresses growing client demand across the pharmaceutical supply chain.

“This expansion marks a major step in our strategic goal to enhance our presence in the United States. As a crucial market with considerable growth opportunities, it allows us to serve our existing clients more effectively and attract new ones.” said Dexter Tjoa, CEO of Tjoapack. 

“We’ve invested heavily in automating our core processes, not only within packaging lines but throughout our cross-company workflows with customers and material vendors. This allows us to reduce human error and enhance accuracy, speed, and flexibility, which ultimately benefits our clients..” 

The Tjoapack US expansion builds on a series of enhancements to Tjoapack’s injectable packaging infrastructure over the past two years, including:

  • Automated vial packaging line: Commissioned and validated in May 2025, the fully integrated line features high-speed labeling, cartoning, and serialization capabilities, with an annual output of 15–20 million vials.

  • Semi-automated auto-injector packaging line: Commissioned and validated in September 2025, this line enables advanced labeling, cartoning, and serialization functionality.

  • Cold storage expansion: A 2.5x increase in capacity went online in October 2024, adding 160 pallet spaces for products requiring 2–8°C storage conditions.

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close